Table 2.
1-Month VT Recurrence | |||||
AVG | XGB, RFE | MLP, PI | RF, PI | XGB, PI | |
HD instability | 1 | 0 | 0 | 0 | 6 |
LVEF | 2 | 1 | 4 | 2 | 1 |
TAPSE | 3 | 7 | 1 | 3 | 4 |
Age | 4 | 3 | 13 | 4 | 0 |
Clinical VT eliminated | 5 | 2 | 3 | 5 | 12 |
LVESD | 6 | 4 | 12 | 1 | 5 |
ICD shock | 7 | 9 | 2 | 7 | 9 |
Clinical VT cycle length | 8 | 6 | 14 | 6 | 2 |
E wave DT | 9 | 5 | 10 | 11 | 3 |
Electrical storm | 10 | 8 | 6 | 9 | 8 |
MR | 11 | 10 | 8 | 8 | 10 |
Incessant VT | 12 | 11 | 5 | 13 | 11 |
Inducible VT morphologies | 13 | 16 | 7 | 10 | 13 |
NYHA | 14 | 13 | 15 | 15 | 7 |
All VTs eliminated | 15 | 12 | 11 | 14 | 15 |
Atrial fibrillation | 16 | 15 | 9 | 16 | 14 |
TR III-IV | 17 | 14 | 16 | 12 | 16 |
1-year VT recurrence | |||||
AVG | XGB, RFE | MLP, PI | RF, PI | XGB, PI | |
LVESD | 1 | 1 | 4 | 0 | 0 |
Inducible VT morphologies | 2 | 0 | 0 | 1 | 7 |
MR | 3 | 4 | 1 | 2 | 6 |
ICD shock | 4 | 6 | 2 | 3 | 9 |
Age | 5 | 2 | 13 | 5 | 1 |
E wave DT | 6 | 5 | 6 | 7 | 3 |
LVEF | 7 | 3 | 12 | 8 | 2 |
HD instability | 8 | 8 | 3 | 4 | 10 |
TAPSE | 9 | 7 | 7 | 9 | 4 |
Incessant VT | 10 | 9 | 5 | 11 | 11 |
Clinical VT cycle length | 11 | 10 | 16 | 6 | 5 |
NYHA | 12 | 11 | 8 | 10 | 8 |
All VTs eliminated | 13 | 13 | 10 | 12 | 13 |
TR III-IV | 14 | 12 | 14 | 13 | 12 |
Electrical storm | 15 | 14 | 9 | 16 | 14 |
Atrial fibrillation | 16 | 15 | 11 | 14 | 15 |
Clinical VT eliminated | 17 | 16 | 15 | 15 | 16 |
HD: hemodynamic; LVEF: left ventricular ejection fraction; VT: ventricular tachycardia; LVESD: left ventricular end systolic diameter; DT: deceleration time; TAPSE: tricuspid annular plane systolic excursion; ICD: implantable cardioverter defibrillator; MR: mitral regurgitation; TR: tricuspid regurgitation; XGB, RFE; Extreme gradient boosting sing recursive feature elimination; MLP, PI: Multilayer perceptron combined with permutation importances; RF, PI: random forest combined with permutation importances; XGB, PI: Extreme gradient boosting combined with permutation importances; AVG: average.